Trials / Completed
CompletedNCT03383315
Role of Prophylactic Metoclopramide With Tramadol in Trauma Patients
Role of Prophylactic Metoclopramide With Tramadol in Trauma Patients: A Randomised, Double Blind Placebo Controlled Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 191 (actual)
- Sponsor
- University of Malaya · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Tramadol is widely used as analgesic in trauma patients. However, it causes side effects, most notably nausea and vomiting. This study aim to determine the role of prophylactic metoclopramide in preventing tramadol induced nausea and vomiting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tramadol | One dose of intravenous tramadol 50mg |
| DRUG | Metoclopramide | One dose of intravenous metoclopramide 10mg |
| DRUG | Placebo | Sodium chloride 0.9% |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2017-09-30
- Completion
- 2017-09-30
- First posted
- 2017-12-26
- Last updated
- 2017-12-26
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT03383315. Inclusion in this directory is not an endorsement.